Abstract
AbstractThe wild Tasmanian devil (Sarchophilus harrisii) population has suffered a devastating decline due to two clonal transmissible cancers. Devil facial tumor 1 (DFT1) was first observed in 1996, followed by a second genetically distinct transmissible tumor, devil facial tumor 2 (DFT2), in 2014. DFT1/2 frequently metastasize, with lymph nodes being common metastatic sites. Downregulation of MHC-I by DFT1 cells is a primary means of evading allograft immunity aimed at polymorphic MHC-I proteins. DFT2 cells constitutively express MHC-I, and MHC-I is upregulated on DFT1/2 cells by interferon gamma, suggesting other immune evasion mechanisms may contribute to overcoming allograft and anti-tumor immunity. Human clinical trials have demonstrated PD1/PDL1 blockade effectively treats patients showing increased expression of PD1 in tumor draining lymph nodes, and PDL1 on peritumoral immune cells and tumor cells. The effects of DFT1/2 on systemic immunity remain largely uncharacterized. This study applied the open-access software QuPath to develop a semiautomated pipeline for whole slide analysis of stained tissue sections to quantify PD1/PDL1 expression in devil lymph nodes. The QuPath protocol provided strong correlations to manual counting. PD-1 expression was approximately 10-fold higher than PD-L1 expression in lymph nodes and was primarily expressed in germinal centers, whereas PD-L1 expression was more widely distributed throughout the lymph nodes. The density of PD1 positive cells was increased in lymph nodes containing DFT2 metastases, compared to DFT1. This suggests PD1/PDL1 exploitation may contribute to the poorly immunogenic nature of transmissible tumors in some devils and could be targeted in therapeutic or prophylactic treatments.
Publisher
Cold Spring Harbor Laboratory
Reference60 articles.
1. Lifetime cancer prevalence and life history traits in mammals;Evol Med Public Health,2020
2. Flies AS , Darby JM , Lennard PR , Murphy PR , Ong CEB , Pinfold TL , et al. A novel system to map protein interactions reveals evolutionarily conserved immune evasion pathways on transmissible cancers. Sci Adv. 2020 Jul 1;6(27).
3. Clonal Origin and Evolution of a Transmissible Cancer
4. Baez-Ortega A , Gori K , Strakova A , Allen JL , Allum KM , Bansse-Issa L , et al. Somatic evolution and global expansion of an ancient transmissible cancer lineage. Science [Internet]. 2019 Aug 2 [cited 2022 Oct 10];365(6452). Available from: /pmc/articles/PMC7116271/
5. Transmission of devil facial-tumour disease